Weekly watch — every Wednesday

Clinical genomics, read and reviewed for you

Every week, the most relevant publications in constitutional genetics, hereditary cancer, pharmacogenomics and bioinformatics — curated, scored against a public grid and reviewed by a medical biologist. Free, ad-free.

890
articles reviewed
292
genes covered
22
weeks published
~1,200
screened / week

Every week, ~1,200 publications are screened down to a curated, scored selection — over ~27,200 publications examined since launch.

This week on Geno'X

Four domains, one report per week each.

Featured this week· Bioinformatics & AI · 9/10
Rare disease undiagnosed after genome sequencing

Serum proteomic profiling with the Olink Explore 1536 assay (1,463 proteins) was performed in 424 rare disease patients from the 100,000 Genomes Project who remained without a genetic diagnosis after genome sequencing. In 13 patients, low serum protein outliers (z-score < -2) led to a confirmed genetic diagnosis by resolving a variant of uncertain significance or by prioritizing genes for targeted genome reanalysis. In 23 further patients (64% of findings), convergence between low protein outliers and Exomiser-ranked variants yielded candidate gene-disease links, including a heterozygous missense variant in TIE1 (gnomAD minor allele frequency 0.006%) found only in a patient with markedly low serum TIE1 (z-score = -5.12) and his father, both affected by the same monogenic cardiac disorder. Missense (52.5%) and splice region (27.5%) variants accounted for most prioritized variants.

Observatory

The watch in numbers

Selection funnel, score distribution, most-covered genes — the full curation mechanics, in the open.

Explore the watch in numbers
~1,200
screened / wk
3.4 %
selected
292
genes

How it works

1. Exhaustive collection

Every week, PubMed, around a hundred specialty journals and bioRxiv/medRxiv preprints are screened across all 4 domains.

2. Transparent scoring

Each article is scored out of 10 against a public 5-criteria grid — clinical impact first. The score breakdown is shown on every article page.

3. Signed expert analysis

Every selected article is read and reviewed by a medical biologist: bilingual FR/EN summary and critical perspective — no black-box generated digest.

The full scoring grid is public: see the methodology.

Who is behind Geno'X?

Dr Thibaut Benquey

Geno'X Veille is published by Dr Thibaut Benquey, a medical biologist specializing in constitutional genomics (WGS/WES) — from rare disease diagnosis to the clinical applications of next-generation sequencing. Every article is personally curated, scored and reviewed: no mass-generated content, no black box.

Follow on LinkedIn

Why it's free

Geno'X Veille is a personal project — no ads, no sponsors, no sponsored content. No data is ever sold. The goal isn't commercial: it's to make clinical-genomics literature monitoring accessible to the whole community — biologists, geneticists, residents, genetic counsellors.

If you find the project useful, you can support hosting and curation time via Ko-fi — entirely optional.

Support on Ko-fi
Weekly report in your inbox

Every Wednesday · Annotated selection · Free · Unsubscribe anytime